Stay updated on Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.

Latest updates to the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check20 days agoChange DetectedA site-wide notice about government funding and NIH operating status was removed, not affecting the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedNo additions or deletions were detected on the Study Details page. The content and structure appear consistent with prior versions.SummaryDifference0.4%

- Check63 days agoChange DetectedUpdate adds a government operating-status notice and increments version to v3.2.0; it removes the Mature T-cell and NK-cell non-Hodgkin lymphoma resource (v3.1.0).SummaryDifference3%

- Check70 days agoChange DetectedPage version metadata updated to v3.1.0; older version tag v3.0.2 removed; a chemical name (Methylprednisolone Acetate) was deleted from the content.SummaryDifference0.2%

- Check85 days agoChange DetectedThe revision tag was updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.